Skip to main content
European Commission logo print header

Development of antagonists that disrupt the hyperactivated camp signalling pathway in immunodeficiencies as immunostimulatory therapy (NEW CAMP ANTAGONISTS)

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

CRS - Cooperative research contracts

Coordinatore

LAURAS AS
Contributo UE
Nessun dato
Indirizzo
Gaustadalleen 21
0349 OSLO
Norvegia

Mostra sulla mappa

Costo totale
Nessun dato

Partecipanti (5)